Subscribe to
our newsletters

Subscribe to our newsletters!

Subscribe to our newsletter and get the latest news from the Nordics straight to your inbox.

Search in Nordic Life Science Insight

-
February 18, 2020
Medicon Valley Alliance

Merck 2020 European Advance Biotech Grant Program – Win €240.000 to Accelerate your Molecule to Clinic faster

Merck 2020 European Advance Biotech Grant Program – Win €240.000 to Accelerate your Molecule to Clinic faster

Apply for the Merck 2020 European Advance Biotech Grant Program and win €240.000 to accelerate your molecule to clinic faster.
Your promising molecule requires resources and support to realize it’s potential. MVA-member, Merck, is accepting applications till March 1st, 2020 for a chance to win Merck’s Bioprocessing /Actives and Formulation product portfolio and consultation.  (Excludes BioReliance® services.)
Learn more and submit a completed application before 1st March 2020. The grant winner will be announced in April 2020.

For more information please contact:

Melissa Nackovski
Sales Development Specialist Emerging Biotech – Nordics
Life Science | Process Solutions
Merck Chemicals & Lifescience AB | Box 3033 | 16903 Solna | Sweden

Mobile Phone: +46 723 62 6331
E-mail:
melissa.nackovski@merckgroup.com
www.merckmillipore.com/emergingbiotech

The post Merck 2020 European Advance Biotech Grant Program – Win €240.000 to Accelerate your Molecule to Clinic faster appeared first on MVA.

Last updated:
February 18, 2020

Medicon Valley Alliance

Medicon Valley Alliance (MVA) is a non-profit membership organization in the Danish-Swedish life science cluster Medicon Valley, which is a part of Greater Copenhagen. Our 245 members, who together employ approximately 140.000 people, represents the region’s triple helix and include universities, hospitals, human life science business, regional governments and service providers.

Click here to read more about us!
Get in touch with us!
Visit us
Send us mail

Apply for the Merck 2020 European Advance Biotech Grant Program and win €240.000 to accelerate your molecule to clinic faster.
Your promising molecule requires resources and support to realize it’s potential. MVA-member, Merck, is accepting applications till March 1st, 2020 for a chance to win Merck’s Bioprocessing /Actives and Formulation product portfolio and consultation.  (Excludes BioReliance® services.)
Learn more and submit a completed application before 1st March 2020. The grant winner will be announced in April 2020.

For more information please contact:

Melissa Nackovski
Sales Development Specialist Emerging Biotech – Nordics
Life Science | Process Solutions
Merck Chemicals & Lifescience AB | Box 3033 | 16903 Solna | Sweden

Mobile Phone: +46 723 62 6331
E-mail:
melissa.nackovski@merckgroup.com
www.merckmillipore.com/emergingbiotech

The post Merck 2020 European Advance Biotech Grant Program – Win €240.000 to Accelerate your Molecule to Clinic faster appeared first on MVA.

Last updated:
February 18, 2020

Medicon Valley Alliance

Medicon Valley Alliance (MVA) is a non-profit membership organization in the Danish-Swedish life science cluster Medicon Valley, which is a part of Greater Copenhagen. Our 245 members, who together employ approximately 140.000 people, represents the region’s triple helix and include universities, hospitals, human life science business, regional governments and service providers.

Click here to read more about us!
Get in touch with us!
Visit us
Send us mail